A genetic medicines customer has selected the company’s binders for commercial development of the customer ... AstraZeneca to evaluate the use of Optimer for targeted delivery of small interfering RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback